Concomitant Use of Methotrexate and CIMZIA in Rheumatoid Arthritis

Dosing Protocol

• The European League Against Rheumatism recommends a methotrexate dose of 15-25 mg weekly, with at least 5 mg of folic acid per week to reduce gastrointestinal and hepatic toxicity without compromising efficacy 1, 2, 3

Safety Monitoring Requirements

• The American College of Rheumatology suggests baseline assessment including complete blood count, liver function tests, creatinine, hepatitis B/C serology, tuberculosis screening, and chest radiograph, with monitoring of CBC, creatinine, and liver enzymes every 1-1.5 months until a stable dose is achieved 1, 4, 5
• The European Society for Medical Oncology recommends maintenance monitoring with CBC and liver function tests every 1-3 months, along with clinical assessment at each visit 6, 5

Critical Management Considerations

• The American College of Rheumatology advises interrupting both methotrexate and CIMZIA in cases of infections requiring antibiotics, and resuming after recovery and antibiotic completion 7
• The European League Against Rheumatism recommends holding methotrexate if WBC <3.5×10⁹/L or neutrophils <2×10⁹/L, indicating bone marrow suppression 7

Contraindications

• The American College of Rheumatology contraindicates the use of this combination in pregnancy or planned pregnancy within 3 months, as well as breastfeeding 1, 6